Multi-criteria optimization for planning volumetric-modulated arc therapy for prostate cancer.

We aimed to compare the volumetric-modulated arc therapy (VMAT) plans with or without multi-criteria optimization (MCO) on commercial treatment-planning systems (Eclipse, Varian Medical System, Palo Alto, CA, USA) for patients with prostate cancer. We selected 25 plans of patients with prostate canc...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jongmoo Park, Jaehyeon Park, Sean Oh, Ji Woon Yea, Jeong Eun Lee, Jae Won Park
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/fa1ae9637b864166aef8baae6a7dab00
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fa1ae9637b864166aef8baae6a7dab00
record_format dspace
spelling oai:doaj.org-article:fa1ae9637b864166aef8baae6a7dab002021-12-02T20:14:41ZMulti-criteria optimization for planning volumetric-modulated arc therapy for prostate cancer.1932-620310.1371/journal.pone.0257216https://doaj.org/article/fa1ae9637b864166aef8baae6a7dab002021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0257216https://doaj.org/toc/1932-6203We aimed to compare the volumetric-modulated arc therapy (VMAT) plans with or without multi-criteria optimization (MCO) on commercial treatment-planning systems (Eclipse, Varian Medical System, Palo Alto, CA, USA) for patients with prostate cancer. We selected 25 plans of patients with prostate cancer who were previously treated on the basis of a VMAT plan. All plans were imported into the Eclipse Treatment Planning System version 15.6, and re-calculation and re-optimization were performed. The MCO plan was then generated. The dosimetric quality of the plans was evaluated using dosimetric parameters and dose indices that account for target coverage and sparing of the organs at risk (OARs). We defined the rectum, bladder, and bilateral femoral heads. The VMAT-MCO plan offers an improvement of gross treatment volume coverage with increased minimal dose and reduced maximal dose. In the planning treatment volume, the Dmean and better gradient, homogeneity, and conformity indexes improved despite the increasing hot and cold spots. When implemented through the MCO plan, a steeper fall off the adjacent OARs in the overlap area was achieved to obtain lower dose parameters. MCO generated better sparing of the rectum and bladder through a tradeoff of the increasing dose to the bilateral femoral heads within the tolerable dose constraints. Compared with re-optimization and re-calculation, respectively, significant dose reductions were observed in the bladder (241 cGy and 254 cGy; p<0.001) and rectum (474 cGy and 604 cGy, p<0.001) with the MCO. Planning evaluation and dosimetric measurements showed that the VMAT-MCO plan using visualized navigation can provide sparing of OAR doses without compromising the target coverage in the same OAR dose constraints.Jongmoo ParkJaehyeon ParkSean OhJi Woon YeaJeong Eun LeeJae Won ParkPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 9, p e0257216 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jongmoo Park
Jaehyeon Park
Sean Oh
Ji Woon Yea
Jeong Eun Lee
Jae Won Park
Multi-criteria optimization for planning volumetric-modulated arc therapy for prostate cancer.
description We aimed to compare the volumetric-modulated arc therapy (VMAT) plans with or without multi-criteria optimization (MCO) on commercial treatment-planning systems (Eclipse, Varian Medical System, Palo Alto, CA, USA) for patients with prostate cancer. We selected 25 plans of patients with prostate cancer who were previously treated on the basis of a VMAT plan. All plans were imported into the Eclipse Treatment Planning System version 15.6, and re-calculation and re-optimization were performed. The MCO plan was then generated. The dosimetric quality of the plans was evaluated using dosimetric parameters and dose indices that account for target coverage and sparing of the organs at risk (OARs). We defined the rectum, bladder, and bilateral femoral heads. The VMAT-MCO plan offers an improvement of gross treatment volume coverage with increased minimal dose and reduced maximal dose. In the planning treatment volume, the Dmean and better gradient, homogeneity, and conformity indexes improved despite the increasing hot and cold spots. When implemented through the MCO plan, a steeper fall off the adjacent OARs in the overlap area was achieved to obtain lower dose parameters. MCO generated better sparing of the rectum and bladder through a tradeoff of the increasing dose to the bilateral femoral heads within the tolerable dose constraints. Compared with re-optimization and re-calculation, respectively, significant dose reductions were observed in the bladder (241 cGy and 254 cGy; p<0.001) and rectum (474 cGy and 604 cGy, p<0.001) with the MCO. Planning evaluation and dosimetric measurements showed that the VMAT-MCO plan using visualized navigation can provide sparing of OAR doses without compromising the target coverage in the same OAR dose constraints.
format article
author Jongmoo Park
Jaehyeon Park
Sean Oh
Ji Woon Yea
Jeong Eun Lee
Jae Won Park
author_facet Jongmoo Park
Jaehyeon Park
Sean Oh
Ji Woon Yea
Jeong Eun Lee
Jae Won Park
author_sort Jongmoo Park
title Multi-criteria optimization for planning volumetric-modulated arc therapy for prostate cancer.
title_short Multi-criteria optimization for planning volumetric-modulated arc therapy for prostate cancer.
title_full Multi-criteria optimization for planning volumetric-modulated arc therapy for prostate cancer.
title_fullStr Multi-criteria optimization for planning volumetric-modulated arc therapy for prostate cancer.
title_full_unstemmed Multi-criteria optimization for planning volumetric-modulated arc therapy for prostate cancer.
title_sort multi-criteria optimization for planning volumetric-modulated arc therapy for prostate cancer.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/fa1ae9637b864166aef8baae6a7dab00
work_keys_str_mv AT jongmoopark multicriteriaoptimizationforplanningvolumetricmodulatedarctherapyforprostatecancer
AT jaehyeonpark multicriteriaoptimizationforplanningvolumetricmodulatedarctherapyforprostatecancer
AT seanoh multicriteriaoptimizationforplanningvolumetricmodulatedarctherapyforprostatecancer
AT jiwoonyea multicriteriaoptimizationforplanningvolumetricmodulatedarctherapyforprostatecancer
AT jeongeunlee multicriteriaoptimizationforplanningvolumetricmodulatedarctherapyforprostatecancer
AT jaewonpark multicriteriaoptimizationforplanningvolumetricmodulatedarctherapyforprostatecancer
_version_ 1718374683000176640